Abstract:Bacterial infections from chronic wounds affect about 175 million people each year and are a significant clinical problem. Through the integration of photodynamic therapy (PDT) and chemotherapy, a new photosensitizer consisting of ammonium salt N,N-bis-(2-hydroxyethyl)-N-(6-(4-(10,15,20-trimesitylporphyrin-5-yl) phenoxy) hexane)-N-methanaminium bromide, TMP(+) was successfully synthesized with a total reaction yield of 10%. The novel photosensitizer consists of two parts, a porphyrin photosensitizer part and a quaternary ammonium salt part, to achieve the synergistic effect of photodynamic and chemical antibacterial activity. With the increase of TMP(+) concentration, the diameter of the PCT fiber membranes (POL/COL/TMP(+); POL, polycaprolactone; COL, collagen) gradually increased, which was caused by the charge of the quaternary ammonium salt. At the same time, the antibacterial properties were gradually improved. We finally selected the PCT 0.5% group for the antibacterial experiment, with excellent performance in fiber uniformity, hydrophobicity and biosafety. The antibacterial experiment showed that the modified porphyrin TMP(+) had a better antibacterial effect than others. In vivo chronic wound healing experiments proved that the antibacterial and anti-inflammatory effect of the PCTL group was the best, further confirmed by H&E histological analysis, immunofluorescence and immunohistochemistry mechanism experiments. This research lays the foundation for the manufacture of novel molecules that combine chemical and photodynamic strategies.

Discovery of <i>Meso</i>-(<i>meta</i>-Pyridinium) BODIPY Photosensitizers: <i>In Vitro</i> and <i>In Vivo</i> Evaluations for Antimicrobial Photodynamic Therapy

Amphiphilic Tetracationic Porphyrins Are Exceptionally Active Antimicrobial Photosensitizers: in Vitro and in Vivo Studies with the Free-Base and Pd-chelate

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

BODIPY Photosensitizers for Antibacterial Photodynamic Therapy

Structural Optimization of BODIPY Photosensitizers for Enhanced Photodynamic Antibacterial Activities

Mitochondria-targeting BODIPY-loaded Micelles As Novel Class of Photosensitizer for Photodynamic Therapy

Discovery of a Monoiodo Aza-BODIPY Near-Infrared Photosensitizer: in Vitro and in Vivo Evaluation for Photodynamic Therapy

Metalloporphyrin–indomethacin conjugates as new photosensitizers for photodynamic therapy

Halogen-substituted meso -BODIPY ethers as effective photosensitizers for antimycotic photodynamic therapy

Photosensitizer‐Amplified Antimicrobial Materials for Broad‐spectrum Ablation of Resistant Pathogens in Ocular Infections

Synthesis and evaluation of novel meso -substitutedphenyl dithieno[3,2-b]thiophene-fused BODIPY derivatives as efficient photosensitizers for photodynamic therapy

The positively charged BODIPY@carbon dots nanocomposites for enhanced photomicrobicidal efficacy and wound healing

Novel porphyrin derivative containing cations as new photodynamic antimicrobial agent with high efficiency

A cationic BODIPY photosensitizer decorated with quaternary ammonium for high-efficiency photodynamic inhibition of bacterial growth

BODIPY-based Photosensitizers with Simultaneous Photodynamic Antitumor and Antibacterial Effects

β-Lactamase-Responsive Probe for Efficient Photodynamic Therapy of Drug-Resistant Bacterial Infection

A BODIPY-modified polymeric micelle for sustaining enhanced photodynamic therapy

BOPHY Derivatives as Phototherapeutic Agents for the Photodynamic Inactivation of Microorganisms

Antifungal Effect of a New Photosensitizer Derived from BODIPY on Candida Albicans Biofilms.

Zinc phthalocyanine-bridged periodic mesoporous organosilica nanoparticle as biodegradable photosensitizer for photodynamic therapy

Design of a new porphyrin-based compound and investigation of its photosensitive properties for antibacterial photodynamic therapy